Drug interactions of exenatide were described in eight manuscripts [13, 20,21,22,23, 25, 33, 34], liraglutide in five [17, 19, 24, 26, 34], semaglutide in three [16, 18, 27], and lixisenatide, dulaglutide and albiglutide in two each [14, 15, 29,30,31,32] and synthetic GLP1 in one manuscript [28]
PMID: 21030672 View source Seiwerth S, et al
Obtaining the NEAs Seal of Acceptance requires products to not only exclude certain known irritants and allergens (e.g., formaldehyde, shellac, citrus ingredients, etc.) but also meet specific clinical safety testing requirements.5 This means the product needs to be successfully tested for safety using human subjects
This helps manage the most common side effects including nausea, constipation, and general GI discomfort
Effective Therapy of Transected Quadriceps Muscle in Rat: Gastric Pentadecapeptide BPC 157